0
selected
-
1.
Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women.
Ko, SH, Kim, HS
Nutrients. 2020;12(1)
-
-
-
Free full text
Plain language summary
Menopause is the absence of menstruation due to the loss of ovarian activity with ageing. During this transition period, changes in hormones, primarily the decline in the oestrogen estradiol, give rise to altered lipid metabolism. An unfavourable lipid profile presents a risk for metabolic disorders, such as cardiovascular diseases and type 2 diabetes. Post-menopausal changes also lead to shifts in body fat and fat distribution, resulting in an increased tendency for central fat accumulation and obesity. Obesity is associated with insulin resistance. This susceptibility for weight accumulation is possibly also driven by the age-associated decline in skeletal muscle, which reduces metabolic energy expenditure. This review summarizes the physiology of menopause and postmenopause and the consequential impact on lipid metabolism. In addition, there is a discussion of dietary recommendations, nutritional and plant-derived compounds that could support the management of menopause associated changes in lipid levels, metabolic risk factors and obesity. The recommendations discussed include traditional healthy diets and low-calorie diets, with attention drawn to adequate protein intake. Furthermore, the role of probiotics, nutritional and plant-sourced constituents are considered, including Vitamin D, Omega-3 fatty acids, antioxidants like Vitamin A, β-carotene, Vitamin C and E, genistein, resveratrol, flavonoids, indoles and capsaicin. The authors advocate sourcing these compounds from a varied whole-foods diet, which would minimize nutrient interactions and absorption issues that can occur with supplementation. This review may be of interest to those supporting the nutritional needs of menopausal and post-menopausal women, that are experiencing or are at risk of experiencing metabolic disorders.
Abstract
Menopause is clinically diagnosed as a condition when a woman has not menstruated for one year. During the menopausal transition period, there is an emergence of various lipid metabolic disorders due to hormonal changes, such as decreased levels of estrogens and increased levels of circulating androgens; these may lead to the development of metabolic syndromes including cardiovascular diseases and type 2 diabetes. Dysregulation of lipid metabolism affects the body fat mass, fat-free mass, fatty acid metabolism, and various aspects of energy metabolism, such as basal metabolic ratio, adiposity, and obesity. Moreover, menopause is also associated with alterations in the levels of various lipids circulating in the blood, such as lipoproteins, apolipoproteins, low-density lipoproteins (LDLs), high-density lipoproteins (HDL) and triacylglycerol (TG). Alterations in lipid metabolism and excessive adipose tissue play a key role in the synthesis of excess fatty acids, adipocytokines, proinflammatory cytokines, and reactive oxygen species, which cause lipid peroxidation and result in the development of insulin resistance, abdominal adiposity, and dyslipidemia. This review discusses dietary recommendations and beneficial compounds, such as vitamin D, omega-3 fatty acids, antioxidants, phytochemicals-and their food sources-to aid the management of abnormal lipid metabolism in postmenopausal women.
-
2.
Diet to Reduce the Metabolic Syndrome Associated with Menopause. The Logic for Olive Oil.
Hidalgo-Mora, JJ, Cortés-Sierra, L, García-Pérez, MÁ, Tarín, JJ, Cano, A
Nutrients. 2020;12(10)
-
-
-
Free full text
Plain language summary
Metabolic syndrome (MetS) is a group of risk factors that increase the risk of type 2 diabetes and cardiovascular disease. The rates of MetS are increasing worldwide. Obesity, particularly central obesity is a major determinant of insulin resistance. It is believed that insulin resistance is the driver for MetS. This is a particular concern for women as central obesity is more likely to occur during the menopause, due in part to the hormonal changes. Physical activity and nutrition have been recommended as the first line of defence against MetS with the Mediterranean diet (MD) being one of the healthiest options. Olive oil (OO) is a main component of the MD and contains certain fats and polyphenols which impact inflammation, oxidative stress and support the gut microbiome. This review provides an overview of these benefits most relevant to menopause-associated MetS. A healthy lifestyle, with nutrition as a vital component, needs to be implemented as a primary measure. The healthy diet needs to be easy to follow and effective, two conditions successfully met by the MD. OO may prove especially helpful for women, particularly during this life stage. The clinical evidence, however, is limited by the observational nature of most studies.
Abstract
The rates of metabolic syndrome are increasing in parallel with the increasing prevalence of obesity, primarily due to its concomitant insulin resistance. This is particularly concerning for women, as the years around menopause are accompanied by an increase in visceral obesity, a strong determinant of insulin resistance. A fall in estrogens and increase in the androgen/estrogen ratio is attributed a determining role in this process, which has been confirmed in other physiological models, such as polycystic ovary syndrome. A healthy lifestyle, with special emphasis on nutrition, has been recommended as a first-line strategy in consensuses and guidelines. A consistent body of evidence has accumulated suggesting that the Mediterranean diet, with olive oil as a vital component, has both health benefits and acceptable adherence. Herein, we provide an updated overview of current knowledge on the benefits of olive oil most relevant to menopause-associated metabolic syndrome, including an analysis of the components with the greatest health impact, their effect on basic mechanisms of disease, and the state of the art regarding their action on the main features of metabolic syndrome.
-
3.
Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures.
Rubio-Ruiz, ME, Guarner-Lans, V, Pérez-Torres, I, Soto, ME
International journal of molecular sciences. 2019;20(3)
-
-
-
Free full text
Plain language summary
Sarcopenia is a multifactorial process in which losses occur in both muscle mass and function. Although several studies indicate an association between sarcopenia and metabolic syndrome (MetS), the connection has not been extensively reviewed. The aim of this study is to examine the relationship between sarcopenia and MetS to better understand the mechanisms underlying disease and assess current therapeutic options. According to the existing literature, this study found insulin resistance, inflammation and obesity to be major underlying factors of MetS-related sarcopenia. Based on this information, the authors suggest the best option for managing MetS-related sarcopenia is preventative lifestyle change around diet and exercise until a consensus on a therapeutic treatment can be established.
Abstract
Although there are several reviews that report the interrelationship between sarcopenia and obesity and insulin resistance, the relation between sarcopenia and the other signs that compose the metabolic syndrome (MetS) has not been extensively revised. Here, we review the mechanisms underlying MetS-related sarcopenia and discuss the possible therapeutic measures proposed. A vicious cycle between the loss of muscle and the accumulation of intramuscular fat might be associated with MetS via a complex interplay of factors including nutritional intake, physical activity, body fat, oxidative stress, proinflammatory cytokines, insulin resistance, hormonal changes, and mitochondrial dysfunction. The enormous differences in lipid storage capacities between the two genders and elevated amounts of endogenous fat having lipotoxic effects that lead to the loss of muscle mass are discussed. The important repercussions of MetS-related sarcopenia on other illnesses that lead to increased disability, morbidity, and mortality are also addressed. Additional research is needed to better understand the pathophysiology of MetS-related sarcopenia and its consequences. Although there is currently no consensus on the treatment, lifestyle changes including diet and power exercise seem to be the best options.
-
4.
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease.
Perdomo, CM, Frühbeck, G, Escalada, J
Nutrients. 2019;11(3)
-
-
-
Free full text
Plain language summary
The major established risk factors for non-alcoholic fatty liver disease (NAFLD) include obesity, insulin resistance and dyslipidaemia. This in-depth review looks at research into the effects of macronutrient composition and dietary patterns on NAFLD. Lifestyle modifications leading to weight reduction and/or increased physical activity consistently showed improvements in NAFLD. Based on the reviewed studies, the authors recommend a diet that includes whole grains, mono-unsaturated fatty acids (in moderation), omega 3 poly-unsaturated fatty acids, vegetable protein and fibre, whilst avoiding simple sugars, trans and saturated fats, and red and processed meats. The effects of these macronutrients were independent of weight loss. There was insufficient evidence for a beneficial role of probiotics, resveratrol, coffee, taurine and choline. The Western dietary pattern, characterised by high intakes of saturated fats and fructose, was associated with an increased risk of NAFLD. The Mediterranean Diet (MD), characterised by a high consumption of plant-based foods (whole grains, cereals, seeds, nuts, legumes, vegetables and fruits), moderate consumption of protein-source foods (fish, seafood, and poultry), low to moderate red wine consumption, low consumption of meat, milk and dairy products, was thought to be beneficial. The “Dietary Approach to Stop Hypertension” (DASH) diet, with an emphasis on low intake of sodium, total fat, saturated fat, cholesterol and added sugars, was also found to be beneficial. The effects of low carbohydrate diets were unclear, as any benefits may be due to the associated weight loss rather than the macronutrient composition per se. The authors point out that much of the research is observational (i.e. epidemiological) and that more prospective clinical trials are needed.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a major global health threat due to its growing incidence and prevalence. It is becoming the leading cause of liver disease in addition to its strong association with cardio-metabolic disease. Therefore, its prevention and treatment are of strong public interest. Therapeutic approaches emphasize lifestyle modifications including physical activity and the adoption of healthy eating habits that intend to mainly control body weight and cardio-metabolic risk factors associated with the metabolic syndrome. Lifestyle interventions may be reinforced by pharmacological treatment in advanced stages, though there is still no registered drug for the specific treatment of NAFLD. The purpose of this review is to assess the evidence available regarding the impact of dietary recommendations against NAFLD, highlighting the effect of macronutrient diet composition and dietary patterns in the management of NAFLD.
-
5.
Nutritional issues in patients with obesity and cirrhosis.
Schiavo, L, Busetto, L, Cesaretti, M, Zelber-Sagi, S, Deutsch, L, Iannelli, A
World journal of gastroenterology. 2018;24(30):3330-3346
-
-
-
Free full text
Plain language summary
Non-alcoholic fatty liver disease (NAFLD) occurs when fats accumulate in the liver in the absence of excess alcohol intake and if unmanaged can advance to severe liver disease known as cirrhosis. NAFLD and cirrhosis can be associated with obesity, muscle wastage and nutrient deficiencies. This review of 165 papers aimed to discuss muscle wastage and nutrient deficiencies in patients with obesity and cirrhosis with a view to making supplementation recommendations. The authors first discussed that the risk of muscle wastage in patients with obesity and cirrhosis is high and when combined with obesity may affect other chronic diseases and impact the progression of NAFLD to cirrhosis. The paper then discusses that vitamin and mineral deficiencies are common in patients with cirrhosis possibly due to reduced intake, poor absorption and the reduction of carrier protein production in the liver. Deficiencies in vitamins D and E and zinc and magnesium were extensively featured. Protein and calorie intake were also reviewed and although weight loss should be encouraged in patients with obesity and cirrhosis, over-restriction could exacerbate muscle breakdown. Any low-calorie diets should contain adequate protein content. Bariatric surgery, in patients with obesity and cirrhosis needs to be performed on a case-by-case basis involving many different medical disciplines. It was concluded that obesity and cirrhosis are commonly occurring simultaneously and poses a management challenge for medical professionals. This paper could be used by health care professionals to understand the possible nutritional deficiencies that need to be monitored in patients with obesity and cirrhosis and where bariatric surgery may be indicated.
Abstract
Obesity and metabolic syndrome are considered as responsible for a condition known as the non-alcoholic fatty liver disease that goes from simple accumulation of triglycerides to hepatic inflammation and may progress to cirrhosis. Patients with obesity also have an increased risk of primary liver malignancies and increased body mass index is a predictor of decompensation of liver cirrhosis. Sarcopenic obesity confers a risk of physical impairment and disability that is significantly higher than the risk induced by each of the two conditions alone as it has been shown to be an independent risk factor for chronic liver disease in patients with obesity and a prognostic negative marker for the evolution of liver cirrhosis and the results of liver transplantation. Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble, water-soluble vitamins and trace elements and should be supplemented appropriately. Diet, physical activity and protein intake should be carefully monitored in these fragile patients according to recent recommendations. Bariatric surgery is sporadically used in patients with morbid obesity and cirrhosis also in the setting of liver transplantation. The risk of sarcopenia, micronutrient status, and the recommended supplementation in patients with obesity and cirrhosis are discussed in this review. Furthermore, the indications and contraindications of bariatric surgery-induced weight loss in the cirrhotic patient with obesity are discussed.
-
6.
New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT.
Albert Pérez, E, Mateu Olivares, V, Martínez-Espinosa, RM, Molina Vila, MD, Reig García-Galbis, M
Nutrients. 2018;10(7)
-
-
-
Free full text
Plain language summary
Metabolic Syndrome is the term used to group a cluster of health concerns including overweight, obesity, hypertension, elevated cholesterol, blood glucose intolerance and insulin resistance which together can contribute to the development of Type II Diabetes and Cardiovascular Disease. Diagnosis is usually given if a patient has three or more of these conditions however the diagnosis in children and adolescents is often inconsistent, and so guidelines for therapeutic strategies for metabolic syndrome also vary greatly. This review looked at 9 studies of children aged up to 19 years old, all diagnosed with metabolic syndrome, and given dietary, physical, psychological, and pharmacological interventions, to try and understand what the best clinical approach might be. It was found that a balanced diet combined with aerobic and resistance exercise helped to significantly reduce body mass, more so than the trials which included treatment with Metformin. A balance diet included calorie restriction and carbohydrate reduction, carefully planned around the daily exercise program of 2-3 resistance sessions each week and frequent cardio sessions of differing intensity and duration. They concluded that a minimum of 6 months was needed to reach optimal weight loss and body fat loss. Overall, the findings of this study support diet and physical exercise as beneficial clinical interventions, whilst the use of medication is still unclear.
Abstract
OBJECTIVE To record which interventions produce the greatest variations in body composition in patients ≤19 years old with metabolic syndrome (MS). METHOD search dates between 2005 and 2017 in peer reviewed journals, following the PRISMA method (Preferred Reporting Items for Systematic reviews and Meta-Analyses). The selection criteria were: diagnostic for MS or at least a criterion for diagnosis; randomized clinical trials, ≤19 years of age; intervention programs that use diet and/or exercise as a tool (interventions showing an interest in body composition). RESULTS 1781 clinical trials were identified under these criteria but only 0.51% were included. The most frequent characteristics of the selected clinical trials were that they used multidisciplinary interventions and were carried out in America. The most utilized parameters were BMI (body mass index) in kg/m² and BW (body weight) in kg. CONCLUSIONS Most of the clinical trials included had been diagnosed through at least 2 diagnostic criteria for MS. Multidisciplinary interventions obtained greater changes in body composition in patients with MS. This change was especially prevalent in the combinations of dietary interventions and physical exercise. It is proposed to follow the guidelines proposed for patients who are overweight, obese, or have diabetes type 2, and extrapolate these strategies as recommendations for future clinical trials designed for patients with MS.
-
7.
Anti-Obesity Effects of Medicinal and Edible Mushrooms.
Ganesan, K, Xu, B
Molecules (Basel, Switzerland). 2018;23(11)
-
-
-
Free full text
Plain language summary
Medicinal mushrooms have long been considered healthful due to of their anti-oxidant and anti-inflammatory properties, such as high-quality proteins, polyunsaturated fatty acids, polyphenols etc. More recently they have been analysed for their anti-obesity effects. The health implications of obesity are extensive, often affecting all bodily systems. The purpose of this review was to analyse previous animal studies to determine whether consuming edible mushrooms has a positive effect on obesity related illnesses, such as Type 2 diabetes and cardiovascular disease etc. The authors explore and summarise the different methods used to treat obesity including pharmacotherapy (weight loss drugs), natural products such as Ayurveda medicine and exercise. They present promising results that suggest the therapeutic properties of edible mushrooms have anti-obesity potentials and propose that the findings from animal studies could likely be mirrored in humans and recommend consuming mushrooms to aid weight loss and therefore improve health.
Abstract
Obesity is a group of metabolic disorders caused by multiple factors, including heredity, diet, lifestyle, societal determinants, environment, and infectious agents, which can all lead to the enhancement of storage body fat. Excess visceral fat mass in adipose tissue generate several metabolic disorders, including cardiovascular diseases with chronic inflammation based pathophysiology. The objective of the current review is to summarize the cellular mechanisms of obesity that attenuate by antioxidant potentials of medicinal and edible mushrooms. Studies have showed that mushrooms potentially have antioxidant capacities, which increase the antioxidant defense systems in cells. They boost anti-inflammatory actions and thereby protect against obesity-related hypertension and dyslipidemia. The practice of regular consumption of mushrooms is effective in the treatment of metabolic syndrome, including obesity, and thus could be a good candidate for use in future pharmaceutical or nutraceutical applications.